EMEA-002552-PIP01-19

Key facts

Active substance
Tris(hydroxymethyl)aminomethane trihydrate (PF-05221304-82)
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0098/2020
PIP number
EMEA-002552-PIP01-19
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of non-alcoholic steatohepatitis (NASH)
Route(s) of administration
Oral use
Contact for public enquiries
Pfizer Europe MA EEIG

Tel. +44 1304 6466 07
E-mail: pip_enquiries@pfizer.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating